Myasthenia gravis: vizsgálatok itt: Olaszország
33 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 4. fázisBefejeződöttA Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab
- Where
- Naples, Rome
- Életkor
- 18 év and over
- People
- 75 worldwide
- Run by
- Alexion Pharmaceuticals, Inc.
See details and how to joinNCT07221838 · EU 2025-522555-26-00 - No phaseTaking peopleRegistry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
- Where
- Milan, Naples
- Életkor
- 18 év and over
- People
- 500 worldwide
- Run by
- Alexion Pharmaceuticals, Inc.
See details and how to joinNCT04202341 - No phaseTaking peopleA Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
- Where
- Roma
- People
- 279 worldwide
- Run by
- argenx
See details and how to joinNCT06299748 - 1/2. fázisTaking peopleA Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis
- Where
- Brescia, Milan
- Életkor
- 18 év to 74 év
- People
- 96 worldwide
- Run by
- ImmunAbs Inc.
See details and how to joinNCT07250750 · EU 2025-522406-20-00 - No phaseTaking peopleEarly Ravulizumab Treatment Of Anti- AChR Antibody-Positive Generalized Myasthenia Gravis
- Where
- Bergamo, Bologna, Brescia, Florence, Imperia, Lecco, Messina, Milan, Naples, Novara, Orbassano, Padova, Palermo, Parma, Pavia, Pisa, Roma, Salerno, San Giovanni Rotondo, Sassari, Torino
- Életkor
- 18 év and over
- People
- 40
- Run by
- Alexion Pharmaceuticals, Inc.
See details and how to joinNCT06967480 - No phaseNot yet taking people in OlaszországProteomic Changes in Patients With Myasthenia Gravis and Ravulizumab
- Where
- Roma
- Életkor
- 18 év and over
- People
- 24
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT07337395 - No phaseTaking peopleMarkers of Favorable Response to Complement Inhibitors Therapy
- Where
- Roma
- Életkor
- 18 év and over
- People
- 50
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT06455709 - No phaseTaking peopleAnalysis of the Role of AIRE in Autoimmune Neurological Diseases Associated With Autoantibodies
- Where
- Roma
- Életkor
- 18 év and over
- People
- 40
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT06941584